Sökning: id:"swepub:oai:lup.lub.lu.se:bba07c02-b3a6-457f-b691-61417c54ca63" >
Effects of DPP-4 in...
Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes : A randomized, open-label, 2-arm parallel comparative, exploratory trial
-
- Yabe, Daisuke (författare)
- Kobe university
-
- Eto, Takashi (författare)
- Hakata Clinic
-
- Shiramoto, Masanari (författare)
- Hakata Clinic
-
visa fler...
-
- Irie, Shin (författare)
- Hakata Clinic
-
- Murotani, Kenta (författare)
- Aichi Medical University
-
- Seino, Yusuke (författare)
- Nagoya University
-
- Kuwata, Hitoshi (författare)
- Kansai Electric Power Medical Research Institute (KEPMRI)
-
- Kurose, Takeshi (författare)
- Kansai Electric Power Medical Research Institute (KEPMRI)
-
- Seino, Susumu (författare)
- Kobe university
-
- Ahrén, Bo (författare)
- Lund University,Lunds universitet,Medicin/akutsjukvård, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
-
- Seino, Yutaka (författare)
- Kansai Electric Power Medical Research Institute (KEPMRI)
-
visa färre...
-
(creator_code:org_t)
- 2016-11-29
- 2017
- Engelska.
-
Ingår i: Diabetes, Obesity and Metabolism. - : Wiley. - 1462-8902. ; 19:3, s. 442-447
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://doi.org/10.1...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Dipeptidyl peptidase-4 (DPP-4) inhibitors reduce the risk of hypoglycaemia, possibly through augmentation of glucose-dependent insulinotropic polypeptide (GIP) action, but not that of glucagon-like peptide-1 (GLP-1) on glucagon secretion. To examine this model in Japanese individuals with type 2 diabetes (T2D), the effects of the DPP-4 inhibitor linagliptin on glucagon and other counter-regulatory hormone responses to hypoglycaemia were evaluated and compared with those of the GLP-1 receptor agonist liraglutide in a multi-centre, randomized, open-label, 2-arm parallel comparative, exploratory trial. Three-step hypoglycaemic clamp glucose tests preceded by meal tolerance tests were performed before and after 2-week treatment with the drugs. Glucagon levels were increased during the hypoglycaemic clamp test at 2.5mmol/L. This increase was similar in the linagliptin and liraglutide groups, both before and after the 2-week treatment. Changes in other counter-regulatory hormones (ie, growth hormone, cortisol, epinephrine and norepinephrine) were also similar between the groups, but were suppressed substantially after 2-week treatment compared to baseline. In conclusion, we confirmed that the glucagon response to hypoglycaemia was not affected by linagliptin or liraglutide treatment in Japanese individuals with T2D.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Nyckelord
- GLP-1 receptor agonist
- DPP-4 inhibitor
- Glucagon response
- Hypoglycaemia
- Sympatho-adrenal response
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Yabe, Daisuke
-
Eto, Takashi
-
Shiramoto, Masan ...
-
Irie, Shin
-
Murotani, Kenta
-
Seino, Yusuke
-
visa fler...
-
Kuwata, Hitoshi
-
Kurose, Takeshi
-
Seino, Susumu
-
Ahrén, Bo
-
Seino, Yutaka
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
- Artiklar i publikationen
-
Diabetes, Obesit ...
- Av lärosätet
-
Lunds universitet